title: FDG PET/CT Evidence of Effective Treatment of Cardiac Sarcoidosis With Adalimumab.
abstract: A 53-year-old man with mediastinal lymph node biopsy and cardiac MRI-proven cardiac sarcoidosis (CS) received treatment with pacemaker and steroids. FDG PET/CT showed active CS despite treatment with prednisone and methotrexate. Addition of weekly adalimumab (Humira) injections was introduced for 3 months. Follow-up FDG PET/CT showed complete resolution of CS as well as improvement of other sarcoid lesions in the thoracic lymph nodes.
authors.affiliation: From the Departments of *Radiology and †Medicine, University of Illinois Hospital & Health Sciences System, Chicago, IL.
authors.forename: Christina T
authors.initials: CT
authors.lastname: Miller
authors.forename: Nadera J
authors.initials: NJ
authors.lastname: Sweiss
authors.forename: Yang
authors.initials: Y
authors.lastname: Lu
mesh_terms: D000068879:Adalimumab / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D009202:Cardiomyopathies / Q000000981:diagnostic imaging; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008297:Male; D008875:Middle Aged; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals; D012507:Sarcoidosis / Q000000981:diagnostic imaging / Q000188:drug therapy*; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
chemical_list: D000893:Anti-Inflammatory Agents; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18; D000068879:Adalimumab